Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Sigyn Therapeutics Inc
(OP:
SIGY
)
5.750
UNCHANGED
Streaming Delayed Price
Updated: 2:08 PM EDT, Aug 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
5.750
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
5.750
Today's Range
5.750 - 5.750
52wk Range
0.1000 - 6.340
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
OTCQB Venture Virtual Investor Conference Presentations Now Available for On-Demand Viewing
August 02, 2024
Company Executives Share Vision and Answer Questions at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
BioMedNewsBreaks — Sigyn Therapeutics Inc. (SIGY) Announces Q1 2024 Financial Results
May 15, 2024
Via
Investor Brand Network
Topics
Death
Exposures
Death
Performance
YTD
+4323.08%
+4323.08%
1 Month
+19.79%
+19.79%
3 Month
+19.79%
+19.79%
6 Month
+15.00%
+15.00%
1 Year
+1696.88%
+1696.88%
More News
Read More
Sigyn Therapeutics Reports First Quarter 2024 Financial Results
May 15, 2024
Via
NewMediaWire
Sigyn Therapeutics Reports First Quarter 2024 Financial Results
May 15, 2024
Via
TheNewswire.com
BioMedNewsBreaks – Sigyn Therapeutics Inc. (SIGY) Announces Publication of Article on Emerging Candidate – Sigyn Therapy(TM)
May 07, 2024
Via
Investor Brand Network
Topics
Death
Exposures
COVID-19
Death
Sigyn Therapeutics Discloses Publication of "Sigyn Therapy, an Emerging Candidate to Address Endotoxemia, Sepsis, and Drug-Resistant Viral & Bacterial Infections"
May 07, 2024
Via
NewMediaWire
Exposures
COVID-19
BioMedNewsBreaks — Sigyn Therapeutics Inc. (SIGY) Leveraging Portfolio to Overcome Current Limitations in Healthcare
April 12, 2024
Via
Investor Brand Network
Topics
Death
Exposures
Death
Sigyn Therapeutics Inc. (SIGY) CEO Discusses Company’s Blood Purification Therapies to Address Cancer and Other Life-Threatening Conditions at the Emerging Growth Conference
April 01, 2024
Via
Investor Brand Network
BioMedNewsBreaks — Sigyn Therapeutics Inc. (SIGY) Making Drugs Perform Better
March 27, 2024
Via
Investor Brand Network
Topics
Death
Exposures
Death
BioMedNewsBreaks — Sigyn Therapeutics Inc. (SIGY) Developing Innovative Technologies to Address Critical Healthcare Challenges
March 20, 2024
Via
Investor Brand Network
Topics
Death
Exposures
Death
BioMedNewsBreaks – Sigyn Therapeutics Inc. (SIGY) Filling Gap in Therapeutic Antibody Treatment Space
March 15, 2024
Via
Investor Brand Network
Topics
Death
Exposures
Death
BioMedNewsBreaks – Sigyn Therapeutics Inc. (SIGY) Announces CEO Presentation at Upcoming Emerging Growth Conference
March 05, 2024
Via
Investor Brand Network
Topics
Death
Exposures
Death
Sigyn Therapeutics to Present at Tomorrow's Emerging Growth Conference
March 05, 2024
Via
NewMediaWire
Sigyn Therapeutics Inc. (SIGY) Therapeutic Candidates to Overcome Limitations in Healthcare
March 05, 2024
Via
Investor Brand Network
Sigyn Therapeutics Inc. (SIGYD) Completes Reverse Stock Split, Releases Year-End Financial Report for 2023
February 27, 2024
Via
Investor Brand Network
Sigyn Therapeutics Announces Filing of 2023 Annual Report on SEC Form 10-K
February 21, 2024
Via
NewMediaWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
BioMedNewsBreaks – Sigyn Therapeutics Inc. (SIGY, SIGYD) Announces Implementation of a 1-for-40 Reverse Split
February 02, 2024
Via
Investor Brand Network
Topics
Death
Exposures
Death
Sigyn Therapeutics Completes Reverse Stock Split
February 01, 2024
Via
NewMediaWire
InvestorNewsBreaks – Sigyn Therapeutics Inc. (SIGY) to Implement 1-for-40 Reverse Split
January 30, 2024
Via
Investor Brand Network
Topics
Death
Exposures
Death
Sigyn Therapeutics Announces Reverse Stock Split
January 30, 2024
Via
NewMediaWire
Sigyn Therapeutics Announces Reverse Stock Split
January 30, 2024
Via
TheNewswire.com
BioMedNewsBreaks — Why Sigyn Therapeutics Inc. (SIGY) Is ‘One to Watch’
January 24, 2024
Via
Investor Brand Network
Topics
Death
Exposures
Death
Sigyn Therapeutics Inc. (SIGY) Is ‘One to Watch’
January 08, 2024
Via
Investor Brand Network
BioMedNewsBreaks – Sigyn Therapeutics Inc. (SIGY) CEO Releases Shareholder Letter Outlining Opportunities, Challenges, Processes
January 04, 2024
Via
Investor Brand Network
Topics
Death
Exposures
Death
Product Safety
Sigyn Therapeutics Releases Letter to Shareholders
January 04, 2024
Via
NewMediaWire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.